Macular Degeneration, Diabetic Retinopathy Reversed

Dr. Zhang.jpg

Dr. Kang Zhang, MD, PhD, Associate Professor and an RPB Lew R. Wasserman Merit Awardee at the University of Utah, John A. Moran Eye Center uses a state-of-the-art genetic analyzer to accelerate the discovery of genes involved in blinding eye diseases.

Two leading causes of blindness can be reversed or even prevented by drugs that activate a protein found in blood vessel cells. The discovery is an example of basic science research yielding a discovery with direct clinical applications.

top

March 20, 2008

Diabetic Retinopathy

Related News: Diabetic Retinopathy

New Grants for Big Data Research to Improve Vision Care

Researchers Build An “Aging Clock” To Help Treat Eye Disease

The new way to measure ocular aging opens treatment avenues for numerous eye diseases.

RPB-Supported Researcher Makes Progress on Diabetic Retinopathy Treatment

Dr. Akrit Sodhi at Johns Hopkins Medicine has published a new study showing promise for an experimental treatment to prevent or slow vision loss in people with diabetes.

Research to Prevent Blindness Announces New Sight-Saving Vision Research Grants

RPB launches awards in data science and Diabetic Eye Disease.

Watch The Video

RPB Hosts Virtual Event On Diabetic Retinopathy

RPB grantees provide expert advice on DR as part of the "Lunch & Learn" series.

Dr. Semenza and colleague work in his lab

Research to Prevent Blindness Grantee Dr. Gregg Semenza Wins Nobel Prize in Medicine

Dr. Semenza is being recognized for his discoveries related to how cells respond to low oxygen levels, which have implications for the treatment of cancer, eye diseases and more.